| abstract |
The present invention is directed to a compound of formula (I) which is an inhibitor of factor Xa or a pharmaceutically acceptable salt, ester or prodrug thereof. The present invention relates to intermediates used for the production of such compounds, pharmaceutical compositions comprising such compounds, methods for preventing or treating certain conditions characterized by undesirable thrombus, and coagulation of blood samples The method of preventing this is also targeted. The present invention further includes administering a therapeutically effective amount of a compound of the present invention to a mammal, a chemical intermediate for preventing or treating a condition in the mammal characterized by an undesirable thrombus, a pharmaceutical composition, and Provide a method. |